AbbVie Inc. (ABBV)

• Annual Data
• Quarterly Data

• Annual Data
• Quarterly Data

AbbVie Inc., decomposition of ROE

	ROE	=	ROA	×	Leverage
Dec 31, 2018		=		×
Dec 31, 2017		=		×
Dec 31, 2016		=		×
Dec 31, 2015		=		×
Dec 31, 2014		=		×

Based on: 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-20).

The primary reason for the decrease in Return on Equity (ROE) over 2018 year is the decrease in Financial Leverage.

• Annual Data
• Quarterly Data

AbbVie Inc., decomposition of ROE

	ROE	=	Net Profit Margin	×	Asset Turnover	×	Leverage
Dec 31, 2018		=		×		×
Dec 31, 2017		=		×		×
Dec 31, 2016		=		×		×
Dec 31, 2015		=		×		×
Dec 31, 2014		=		×		×

Based on: 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-20).

The primary reason for the decrease in Return on Equity (ROE) over 2018 year is the decrease in Financial Leverage.

AbbVie Inc., decomposition of ROE

	ROE	=	Tax Burden	×	Interest Burden	×	EBIT Margin	×	Asset Turnover	×	Leverage
Dec 31, 2018		=		×		×		×		×
Dec 31, 2017		=		×		×		×		×
Dec 31, 2016		=		×		×		×		×
Dec 31, 2015		=		×		×		×		×
Dec 31, 2014		=		×		×		×		×

Based on: 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-20).

The primary reason for the decrease in Return on Equity (ROE) over 2018 year is the decrease in Financial Leverage.

• Annual Data
• Quarterly Data

AbbVie Inc., decomposition of ROA

	ROA	=	Net Profit Margin	×	Asset Turnover
Dec 31, 2018		=		×
Dec 31, 2017		=		×
Dec 31, 2016		=		×
Dec 31, 2015		=		×
Dec 31, 2014		=		×

Based on: 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-20).

The primary reason for the increase in Return on Assets (ROA) over 2018 year is the increase in Asset Turnover.

AbbVie Inc., decomposition of ROA

	ROA	=	Tax Burden	×	Interest Burden	×	EBIT Margin	×	Asset Turnover
Dec 31, 2018		=		×		×		×
Dec 31, 2017		=		×		×		×
Dec 31, 2016		=		×		×		×
Dec 31, 2015		=		×		×		×
Dec 31, 2014		=		×		×		×

Based on: 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-20).

The primary reason for the increase in Return on Assets (ROA) over 2018 year is the increase in effect of taxes measured by Tax Burden.

AbbVie Inc., decomposition of Net Profit Margin

	Net Profit Margin	=	Tax Burden	×	Interest Burden	×	EBIT Margin
Dec 31, 2018		=		×		×
Dec 31, 2017		=		×		×
Dec 31, 2016		=		×		×
Dec 31, 2015		=		×		×
Dec 31, 2014		=		×		×

Based on: 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-20).

The primary reason for the decrease in Net Profit Margin over 2018 year is the decrease in operating profitability measured by EBIT Margin.